Psychedelic Bulletin #137: Oregon Approves First Psilocybin Service Centre; AMA Approves...

FILAMENT HEALTH TO HOST VIRTUAL INVESTOR UPDATE

Clearmind Medicine Strengthens Scientific Advisory Board with Appointment of Prof. Joseph...

MIND CURE AND LNG ENERGY GROUP ENTER INTO ARRANGEMENT AGREEMENT WITH...

Algernon Pharmaceuticals Announces Closing of Rights Offering

Optimi Health Announces CAD$1.2 Million GMP Psilocybin Supply Agreement for Clinical...

Psychedelics Weekly – Psychedelics and Sports, The Risks of Over-Regulation, and...

COMPASS Pathways plc to announce first quarter 2023 financial results on...

The Top 5 Psychedelic Clinical Trials of 2022

Small Pharma to Present at Upcoming CINP World Congress of Neuropsychopharmacology

Load more